BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

New Therapeutic Targets and Biomarkers: December 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during December 2017. Therapeutic targets are defined as any protein, gene or other...
BioCentury | Dec 13, 2017
Distillery Therapeutics

Cancer

...K. et al. Cancer Res. ; published online Nov. 29, 2017 doi:10.1158/0008-5472.CAN-17-0910 CONTACT: Satoshi Serada, National Institute of Biomedical Innovation...
BioCentury | Dec 5, 2017
Preclinical News

Researchers identify new ovarian cancer target

...The anti-LSR mAb decreased cell proliferation in LSR-expressing cells co-cultured with VLDL compared with vehicle. Jennie Walters National Institute of Biomedical Innovation Lipolysis...
BioCentury | Nov 9, 2017
Finance

The return of big

After a slow second quarter, pharmas have stepped up their activity in public-private partnerships, announcing 13 in 3Q17, compared with only five in the quarter before. The deals bring the third quarter total to 56,...
BioCentury | Apr 11, 2017
Distillery Techniques

Disease models

TECHNOLOGY: Animal models LMP1 / LMP2 -overexpressing mice depleted of T cells and NKT cells could be used to screen therapies for EBV-positive lymphoproliferative disease. Mice with germinal center B cell-specific overexpression of LMP1 and...
BioCentury | Sep 24, 2015
Strategy

Full speed AMED

...the baseball draft." The Center of Innovative Drug Discovery and Development (iD3), part of Japan's National Institute of Biomedical Innovation...
...Science & Technology (MEXT), Tokyo, Japan Ministry of Health, Labour and Welfare (MHLW), Tokyo, Japan National Institute of Biomedical Innovation...
BioCentury | Jun 2, 2014
Company News

Japan BCG, Dainippon Sumitomo, Innovation Network Corp. deal

...technological and management support for next-generation businesses. Create Vaccine is developing the vaccines with Japan's National Institute of Biomedical Innovation...
BioCentury | Apr 17, 2014
Translation in Brief

Translational tidbits

...the latest round, the GHIT Fund awarded $12.5 million in aggregate to 4 partnerships. Japan's National Institute of Biomedical Innovation...
...Research Council , London, U.K. MedImmune LLC , Gaithersburg, Md. Merck KGaA (Xetra:MRK), Darmstadt, Germany National Institute of Biomedical Innovation...
...Ltd. (Tokyo:4523); Merck KGaA Aeras; Drugs for Neglected Diseases initiative; Liverpool School of Tropical Medicine; National Institute of Biomedical Innovation...
BioCentury | Mar 24, 2014
Company News

Japan BCG, Astellas, Dainippon Sumitomo, Eisai, Merck KGaA, Aeras, Drugs for Neglected Diseases initiative (DNDi), Liverpool School of Tropical Medicine (LSTM),

...within one to two years. GHIT also announced additional funding of $5.7 million to Japan's National Institute of Biomedical Innovation...
...Diseases initiative (DNDi) , Geneva, Switzerland Liverpool School of Tropical Medicine (LSTM) , Liverpool, U.K. National Institute of Biomedical Innovation...
BioCentury | Mar 13, 2014
Distillery Therapeutics

Indication: Other

...Proc. Natl. Acad. Sci. USA; published online Feb. 10, 2014; doi:10.1073/pnas.1319268111 Contact: Ken J. Ishii, National Institute of Biomedical Innovation...
Items per page:
1 - 10 of 19
BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

New Therapeutic Targets and Biomarkers: December 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during December 2017. Therapeutic targets are defined as any protein, gene or other...
BioCentury | Dec 13, 2017
Distillery Therapeutics

Cancer

...K. et al. Cancer Res. ; published online Nov. 29, 2017 doi:10.1158/0008-5472.CAN-17-0910 CONTACT: Satoshi Serada, National Institute of Biomedical Innovation...
BioCentury | Dec 5, 2017
Preclinical News

Researchers identify new ovarian cancer target

...The anti-LSR mAb decreased cell proliferation in LSR-expressing cells co-cultured with VLDL compared with vehicle. Jennie Walters National Institute of Biomedical Innovation Lipolysis...
BioCentury | Nov 9, 2017
Finance

The return of big

After a slow second quarter, pharmas have stepped up their activity in public-private partnerships, announcing 13 in 3Q17, compared with only five in the quarter before. The deals bring the third quarter total to 56,...
BioCentury | Apr 11, 2017
Distillery Techniques

Disease models

TECHNOLOGY: Animal models LMP1 / LMP2 -overexpressing mice depleted of T cells and NKT cells could be used to screen therapies for EBV-positive lymphoproliferative disease. Mice with germinal center B cell-specific overexpression of LMP1 and...
BioCentury | Sep 24, 2015
Strategy

Full speed AMED

...the baseball draft." The Center of Innovative Drug Discovery and Development (iD3), part of Japan's National Institute of Biomedical Innovation...
...Science & Technology (MEXT), Tokyo, Japan Ministry of Health, Labour and Welfare (MHLW), Tokyo, Japan National Institute of Biomedical Innovation...
BioCentury | Jun 2, 2014
Company News

Japan BCG, Dainippon Sumitomo, Innovation Network Corp. deal

...technological and management support for next-generation businesses. Create Vaccine is developing the vaccines with Japan's National Institute of Biomedical Innovation...
BioCentury | Apr 17, 2014
Translation in Brief

Translational tidbits

...the latest round, the GHIT Fund awarded $12.5 million in aggregate to 4 partnerships. Japan's National Institute of Biomedical Innovation...
...Research Council , London, U.K. MedImmune LLC , Gaithersburg, Md. Merck KGaA (Xetra:MRK), Darmstadt, Germany National Institute of Biomedical Innovation...
...Ltd. (Tokyo:4523); Merck KGaA Aeras; Drugs for Neglected Diseases initiative; Liverpool School of Tropical Medicine; National Institute of Biomedical Innovation...
BioCentury | Mar 24, 2014
Company News

Japan BCG, Astellas, Dainippon Sumitomo, Eisai, Merck KGaA, Aeras, Drugs for Neglected Diseases initiative (DNDi), Liverpool School of Tropical Medicine (LSTM),

...within one to two years. GHIT also announced additional funding of $5.7 million to Japan's National Institute of Biomedical Innovation...
...Diseases initiative (DNDi) , Geneva, Switzerland Liverpool School of Tropical Medicine (LSTM) , Liverpool, U.K. National Institute of Biomedical Innovation...
BioCentury | Mar 13, 2014
Distillery Therapeutics

Indication: Other

...Proc. Natl. Acad. Sci. USA; published online Feb. 10, 2014; doi:10.1073/pnas.1319268111 Contact: Ken J. Ishii, National Institute of Biomedical Innovation...
Items per page:
1 - 10 of 19